Antibodies against tumor surface antigens
US7626011B2 · kind B2 · utility
5Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 29, 2007 |
| Grant date | Dec 1, 2009 |
| Priority date | — |
| Expiry date | Apr 5, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/622
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to improved antibodies against tumor surface antigens and their use in the treatment of tumors. Of particular interest are highly stable, humanized, high affinity antibodies against carcinoembryonic antigen (CEA), especially the antibody we have termed sm3E, which is derived from the scFv antibody MFE-23. Such antibodies have the potential for improved therapeutic efficacy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.